CRISPR/Cas9 therapeutics for liver diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CRISPR/Cas9 therapeutics for liver diseases

Published:2018-02-22 Issue:6 Volume:119 Page:4265-4278
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Aravalli Rajagopal N.¹^ORCID,Steer Clifford J.²³

Affiliation:

1. Department of Electrical and Computer EngineeringUniversity of MinnesotaMinneapolisMinnesota

2. Department of MedicineUniversity of MinnesotaMinneapolisMinnesota

3. Department of Genetics, Cell Biology, and DevelopmentUniversity of MinnesotaMinneapolisMinnesota

Funder

Institute of Engineering in Medicine, University of Minnesota

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.26627

Reference152 articles.

1. T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years

2. Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease

3. Gene therapy: Myth or reality?

4. Clinical development of gene therapy: results and lessons from recent successes

5. Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR-Cpf1 system and its applications in animal genome editing;Molecular Genetics and Genomics;2024-08-01

2. Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment;Pharmaceutics;2023-12-30

3. Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy;World Journal of Hepatology;2023-02-27

4. Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases;Science Advances;2022-09-16

5. Preparation of carbon dot as a potential CRISPR/Cas9 plasmid delivery system for lung cancer cells;Minerva Biotecnologica;2020-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3